The KCNK9 gene helps brain cells control their electrical activity, which supports learning, movement, and muscle tone. This gene plays an important role in keeping nerve signals steady. When the active copy of the KCNK9 gene does not work properly, it can cause KCNK9 imprinting syndrome, a rare condition linked to low muscle tone, feeding and sleep problems, developmental delay, and often limited speech.
What is a gene?
Genes are stretches of DNA that provide instructions cells use to make molecules or direct processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Others mainly regulate when specific processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can also shape your response to food, stress, and medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
KCNK9Gene function
What if the gene works
The KCNK9 gene helps make a potassium channel, a protein that lets potassium move across cell membranes. This supports the resting electrical state of nerve cells, especially in the brain, and helps steady signaling.
Risk
What if the gene does not work
Problems with the KCNK9 gene can cause KCNK9 imprinting syndrome, usually when a pathogenic variant is inherited from the mother. Common effects include low muscle tone, feeding trouble, and developmental delay, with severity ranging from mild to more marked.
Treatment
What does that mean for your treatment
No KCNK9-specific treatment or management approach is currently established for pathogenic variants in the KCNK9 gene. The KCNK9 gene is being studied as a possible drug target, and channel-modifying medicines such as mefenamic acid have shown early research interest, but this has not become standard care.
Conditions associated with KCNK9
Gene function
What if the gene works
Your cells use the KCNK9 gene to make a tiny channel that lets potassium move across the cell surface. This steady flow helps keep the cell’s electrical state calm and ready for normal signaling. In everyday terms, this is a key part of what the KCNK9 gene does in nerve cells.
The KCNK9 gene makes a channel protein that sits in the cell membrane. It gives potassium a path to move out of the cell in a steady, low level way.
This potassium flow helps set the resting membrane potential, which is the cell’s usual electrical charge at rest. That steady baseline helps cells stay ready to send signals in a controlled way.
Many nerve cells use this channel to avoid becoming too easily excited. By damping extra electrical activity, it supports smoother communication between cells.
The channel made by the KCNK9 gene responds to changes in acidity around the cell. This helps fine tune potassium flow as conditions shift in the local tissue.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the brain, variants in the KCNK9 gene can affect potassium channel function by making the TASK-3 channel open less well, fold abnormally, or fail to reach the cell surface. Some changes also interfere with channel pairing, which can further reduce the flow of potassium ions. Milder variants may leave some activity, while more severe variants can reduce activity much more and are often linked to earlier or more marked features of KCNK9 imprinting syndrome.
How variants are linked to conditions
Pathogenic variants in the KCNK9 gene cause KCNK9-related syndrome, often called Birk-Barel syndrome, a rare condition associated with low muscle tone, feeding and speech difficulties, developmental delay, and intellectual disability. Some people also have cleft palate, sleep apnea, or learning and behavior differences. In KCNK9 gene variants linked to Birk-Barel syndrome, the condition is usually seen when the altered copy is inherited from the mother.
A variant is not necessarily a diagnosis
In human biology, genetic variants are common and are a normal feature of the general population. Most do not directly affect health and simply reflect natural differences among people. For many genes, a variant connected with a condition points to a possible association, not a certain diagnosis, especially when several genes and environmental influences play a part. In contrast, a single well described variant in a particular gene can sometimes be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KCNK9, risk is mainly determined by whether there is a disease-causing change in the gene, rather than by lifestyle or everyday exposures. Family history can change risk because a child is affected when the changed copy is passed on from the mother; a changed copy inherited from the father usually does not cause the condition.
Inheritance of KCNK9 variants
KCNK9-related conditions follow an unusual parent-of-origin pattern, so how KCNK9 gene variants are inherited depends on which parent passes the variant on. A disease-causing variant typically leads to KCNK9 imprinting syndrome only when it is inherited from the mother or arises as a new variant on the maternal copy. If a mother carries the variant, each child has a 50% chance of inheriting it. If a father carries the variant, it is usually not expected to cause the condition in his children because the paternal copy of the KCNK9 gene is normally switched off.
What does my KCNK9 result mean for my family?
For families with a disease-causing change in the KCNK9 gene, the family meaning depends on which parent’s copy carries the change. This condition is usually only caused when the changed copy comes from the mother, so close relatives on the mother’s side may also want to learn whether they carry it. Some cases happen for the first time in a child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for KCNK9 variants usually uses a blood or saliva sample to read the KCNK9 gene and look for changes in its DNA. Results can show whether a person carries a variant linked to KCNK9 syndrome and may help confirm or clarify a diagnosis.
When should I consider getting a genetic test?
Genetic testing for the KCNK9 gene may be considered when a child has unexplained developmental delay, low muscle tone, major speech delay, and early feeding or sleep-breathing problems, especially when these features occur together. It can also help clarify a family history of the same rare KCNK9-related condition.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medicines work. It studies links between genes and medications to clarify why the same treatment can have different effects in different people. With many drugs, genes help shape how strongly a medicine acts or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the KCNK9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects are more likely. Questions about symptoms, treatment, or medication changes are best discussed with your doctor, who can look at your full health picture and current medicines.
History
The KCNK9 gene entered the medical literature in the early 2000s as researchers mapped genes on chromosome 8 and linked them to inherited neurologic features. In recent decades, awareness of this gene’s role has grown through reports of a rare condition now called KCNK9 imprinting syndrome, also known as Birk-Barel syndrome. A key step came in 2008, when scientists described children with low muscle tone, feeding difficulties, and developmental delay tied to changes affecting the active copy inherited from the mother. That finding drew attention to genomic imprinting, a pattern in which a gene’s effect depends on which parent passed it on. From these first observations, research expanded steadily, and KCNK9 became an important example in the study of parent of origin effects in human genetics.